Skip to content
★ Sign in to follow
BH

Bret Hankey

Bone Biologics Corp
Total declarations
7
Company
1
▲ Purchases (7 ops.)
€174k
▼ Sales (0 ops.)
—

Latest filing published 17 Jan 2020 for Bone Biologics Corp, €174k.

Filing timeline

BuySale
Bret Hankey

Insider track record

Disclosed buys
7
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
7

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Bret Hankey: trading record in brief

All filings by Bret Hankey on record concern Bone Biologics Corp. The record holds 7 filings, for trades running from 17 December 2018 to 2 January 2020.

The open-market record is one-sided, with 7 purchases worth €174k and not one sale. The totals exclude 6 filings filed without an amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2020 alone, the filings show 1 purchase and no sales.

Most recently, on 17 January 2020, the filings show an open-market purchase worth €174k in Bone Biologics Corp. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Bret Hankey

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations6 total
  • ▲
    DirectorExecutivesBone Biologics Corp

    Same trade as the filing by Don Hankey, counted once

    195,000 USD31SEC
    195,000 shares@ US$1.00100.0% of flowCommon StockSEC:0001493152-20-000776:0
    Canonical exit: 1 Apr 2020 (T+90)
  • ▲
    DirectorExecutivesBone Biologics Corp
    0SEC
    553,191 shares0Common StockSEC:0001493152-19-011867:0
    Canonical exit: 4 Nov 2019 (T+90)
  • ▲
    DirectorExecutivesBone Biologics Corp
    0SEC
    85,106 shares0Common StockSEC:0001493152-19-010724:0
    Canonical exit: 13 Oct 2019 (T+90)
  • ▲
    DirectorExecutivesBone Biologics Corp
    0SEC
    1,063,830 shares0Common StockSEC:0001493152-19-009559:0
    Canonical exit: 18 Sept 2019 (T+90)
  • ▲
    DirectorExecutivesBone Biologics Corp
    0SEC
    1,063,830 shares0Common StockSEC:0001493152-19-008226:0
    Canonical exit: 5 Aug 2019 (T+90)
  • ▲
    DirectorExecutivesBone Biologics Corp
    0SEC
    18,009,696 shares0Common StockSEC:0001493152-19-003934:0
    Canonical exit: 17 Mar 2019 (T+90)
  • ▲
    DirectorExecutivesBone Biologics Corp
    0SEC
    1,489,362 shares0Common StockSEC:0001493152-19-003934:1
    Canonical exit: 23 Jun 2019 (T+90)

7 of 6 declarations